Selank Research Overview (also known as Selank nootropic, TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide, Anxiolytic nootropic peptide)
A synthetic heptapeptide derived from the naturally occurring immunoregulatory peptide tuftsin. Studied for anxiolytic effects through GABAergic modulation without sedation or dependence risk, BDNF upregulation in the hippocampus, serotonin system modulation, and immune support. One of the more clinically studied nootropic peptides with human data available.
For broader research context on nootropic compounds, including comparative stacks, cycling considerations, and interaction notes, see the Complete Nootropic Cheat Sheet.
What Is Selank?
Selank is a synthetic heptapeptide combining the tuftsin tetrapeptide (Thr-Lys-Pro-Arg) — a naturally occurring immunopeptide — with an additional Pro-Gly-Pro sequence that confers stability and nootropic activity. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has been studied clinically in Russia for generalized anxiety disorder and demonstrates a unique combination of anxiolytic, nootropic, and immunomodulatory effects.
Anxiolytic Mechanism
Selank's anxiolytic effects are mediated through multiple pathways: it modulates GABAergic transmission (without direct GABA-A receptor agonism like benzodiazepines), increases enkephalin degradation enzyme activity, and normalizes serotonin metabolism in key limbic structures. Crucially, it produces anxiolysis without sedation, cognitive impairment, dependence, or withdrawal.
Nootropic, BDNF, and Immune Effects
Selank stimulates BDNF expression in the hippocampus and frontal cortex — contributing to improvements in memory consolidation, learning, and cognitive clarity documented in clinical studies. Its tuftsin component provides immunomodulatory activity: enhancing natural killer cell activity, macrophage phagocytosis, and IL-2 production. This dual anxiolytic-immunostimulant profile makes it relevant for stress-induced immunosuppression, where anxiety and impaired immune function co-occur.
Quick Reference
| Literature-Reported Dose Range | 250-500mcg daily |
| Literature-Reported Frequency | Once daily morning, or split twice daily |
| Literature-Reported Cycle Length | 2-8 weeks, break not required but recommended |
| Literature-Reported Washout | 1-2 weeks between cycles (optional) |
| Storage | Refrigerate 2-8°C, protect from light and heat |
| Sites Reported in Studies | Abdomen, thigh, or upper arm subcutaneously |
| Timing | Morning for cognitive benefits, evening for anxiety |
Research Indications
Anxiety
Generalized Anxiety Disorder
Clinical trials demonstrate significant reduction in anxiety symptoms comparable to benzodiazepines but without sedation, amnesia, or dependence potential
Post-Traumatic Stress Disorder
Emerging research shows effectiveness in PTSD treatment, helping stabilize stress responses and emotional regulation without cognitive impairment
Social Anxiety and Performance Stress
Reduces anticipatory anxiety and social stress while maintaining cognitive clarity and emotional stability during challenging situations
Cognitive
Memory and Learning Enhancement
Improves memory consolidation and learning processes, particularly effective in subjects with initially poor cognitive performance
Attention and Focus Improvement
Enhances concentration and mental clarity without stimulant effects, beneficial for ADHD-like symptoms and cognitive fatigue
Neuroprotective Effects
Increases BDNF expression supporting neuroplasticity, potentially protective against age-related cognitive decline and neurodegenerative processes
Immune
Immune System Modulation
Balances T-helper cell cytokines and modulates IL-6 expression, supporting healthy immune responses without over-activation
Antiviral Activity
Demonstrated effectiveness against multiple viruses including influenza, herpes simplex, and cytomegalovirus through immune enhancement
Inflammation Regulation
Modulates inflammatory gene expression and reduces chronic inflammation markers while supporting appropriate immune responses
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Mild anxiety relief | 250mcg daily | Once daily | SubQ |
| Moderate anxiety/cognitive enhancement | 250mcg twice daily | Morning and evening | SubQ |
| Intensive anxiety/stress management | 500mcg daily | Divided doses | SubQ |
| Cognitive enhancement/nootropic use | 250-350mcg daily | Morning only | SubQ |
| PTSD/trauma support | 250mcg twice daily | Consistent timing | SubQ |
| Immune support during stress | 250mcg daily | Once daily for 2-4 weeks | SubQ |
Timing
Recommended administration window: morning for cognitive benefits, evening for anxiety. Typical onset: anxiety relief 30-60 min, cognitive effects 1-3 days, peak benefits 1-2 weeks.
Peptide Interactions
This pairing includes GH/IGF-axis signaling. Published evidence for the exact combination is limited; define exposure timing and monitor protocol-relevant endocrine and tolerability endpoints rather than assuming additive benefit.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
This pairing includes GH/IGF-axis signaling. Published evidence for the exact combination is limited; define exposure timing and monitor protocol-relevant endocrine and tolerability endpoints rather than assuming additive benefit.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
No known interactions, complementary mechanisms for stress response and neural protection
Both enhance BDNF and cognitive function through different pathways - may complement each other
Selank provides anxiolytic effects while racetams enhance cognitive stimulation
Similar GABAergic effects may potentiate sedation - medical supervision recommended
Can be combined with SSRIs for enhanced mood regulation - monitor for serotonin effects
Selank reduces anxiety while modafinil enhances wakefulness - balanced cognitive enhancement
Both affect GABA system - combination may cause excessive sedation or unpredictable effects
Reported Research Timeline
01Mild anxiety reduction within 30-60 minutes of injection
02Improved mental clarity and focus within 1-3 days
03Enhanced stress resilience and emotional stability by week 1
04Better sleep quality and reduced nervous tension
05Cognitive enhancement effects peak around 1-2 weeks
06No sedation, drowsiness, or cognitive impairment
07Potential mild injection site irritation initially
08Sustained benefits may last several days after discontinuation
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Start with lowest effective dose (250mcg) to assess individual response
Selank has excellent safety profile with minimal reported side effects
No known tolerance, dependence, or withdrawal issues reported
Can be safely combined with most medications under medical supervision
Store properly refrigerated to maintain peptide stability and potency
Use sterile injection techniques to prevent infection
Consult healthcare provider if taking multiple psychiatric medications
Seek Medical Attention If:
Severe allergic reactions (rash, difficulty breathing, swelling)
Persistent injection site reactions or signs of infection
Unusual mood changes or increased anxiety (rare)
Severe headaches or neurological symptoms
Any signs of contaminated product (unusual smell, cloudiness)
Unexplained fatigue or cognitive impairment
Skin reactions or immune system hypersensitivity
Quality Indicators
Verified Marker
White to off-white powder
High-quality Selank appears as light, fluffy lyophilized powder without clumping or discoloration
Verified Marker
Clear reconstituted solution
Properly reconstituted Selank should be completely clear and colorless without particles or cloudiness
Verified Marker
Proper labeling and batch information
Legitimate Selank includes clear peptide sequence, purity testing, batch numbers, and expiration dates
Verified Marker
Appropriate packaging and storage
Should arrive properly refrigerated or with cold packs, sealed vials with intact rubber stoppers
Quality Concern
Yellowing, clumping, or moisture exposure
Discolored, clumped, or damp powder indicates degradation, improper storage, or contamination
Quality Concern
Persistent cloudiness after reconstitution
Cloudiness that doesn't clear indicates peptide aggregation, contamination, or poor quality
Acceptable Range
Unusual smell or burning sensation
Fresh Selank should be odorless - strong smells or burning may indicate bacterial contamination
Research Citations
- GABAergic Neurotransmission Gene Expression (2016)
Rat frontal cortex | 300 μg/kg | Real-time PCR analysis - BDNF Expression Enhancement Study (2010)
Rat hippocampus | 250-500 μg/kg | 24-hour measurement - Generalized Anxiety Disorder Clinical Trial (2008)
Human subjects | GAD and neurasthenia | Multi-week treatment - Memory Consolidation Enhancement (2007)
Rat models | Learning paradigms | Head-to-head with Piracetam - Functional Connectomic Approach to Studying Selank and Semax Effects
Panikratova YR, Lebedeva IS, Sokolov OY, 2020, Dokl Biol Sci - Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
Konstantinopolsky MA, Chernyakova IV, Kolik LG, 2022, Bull Exp Biol Med - Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
Kolik LG, Nadorova AV, Antipova TA, 2019, Bull Exp Biol Med - The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats
Kozlovskii II, Danchev ND, 2003, Neurosci Behav Physiol - GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Filatova E, Kasian A, Kolomin T, 2017, Front Pharmacol
Research Focus
Anxiety reduction, Cognitive enhancement, Nootropic, Immunomodulation, BDNF, Anti-stress
Verified Vendors Carrying Selank
Frequently Asked Questions
What should researchers watch for with Selank?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Selank?
Mild anxiety reduction within 30-60 minutes of injection
How is Selank typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →